Researchers sought to examine sex-related differences in the association between depression subtypes and CVD risk in veterans ...

Parental mental disorders were associated with significant cross-disorder and parent-of-origin patterns of psychiatric risk in offspring.

Definium Therapeutics (NASDAQ:DFTX) outlined its clinical pipeline and upcoming data catalysts at the Leerink Partners Global ...

Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for ...

Alembic Pharma receives US FDA final approval for paroxetine extended-release tablets: Our Bureau, Mumbai Monday, March 30, 2026, 16:15 Hrs [IST] Alembic Pharmaceuticals Limited ( ...

Neuronetics, Inc. 2026 turnaround? New CEO Dan Reuvers and the Greenbrook deal drove revenue growth—see key valuation and debt risks. Click for this STIM update.

Alembic Pharmaceuticals receives USFDA approval for generic Paroxetine extended-release tablets for mental health conditions ...

The Company's Breakthrough Test Evaluates How a Wide Panel of Antidepressants Affect Each Patient's Brain, Supporting ...

Exposure to adverse childhood experiences is linked to an increased risk for treatment-resistant depression in adulthood, ...

Johnson & Johnson (NYSE:JNJ) is one of the best pharma stocks to invest in now. Johnson & Johnson (NYSE:JNJ) announced on ...

Government should focus on building energy independence, meeting our climate targets and become less dependent on fossil ...